华润双鹤：关于全资子公司华润赛科药业有限责任公司比索洛尔氨氯地平片获得药品注册证书的公告

Core Viewpoint - China Resources Double Crane announced that its wholly-owned subsidiary, China Resources Saike Pharmaceutical Co., Ltd., has received the drug registration certificate for Bisoprolol Amlodipine Tablets from the National Medical Products Administration [2] Group 1 - The drug registration certificate is a significant regulatory milestone for the company, indicating approval for the marketing of Bisoprolol Amlodipine Tablets in China [2] - This approval may enhance the company's product portfolio and market presence in the cardiovascular medication sector [2]